Medico Remedies Limited (BOM:540937)
India · Delayed Price · Currency is INR 38.20
+0.05 (0.13%)
At close: Aug 29, 2025
Medico Remedies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 100.93 | 82.91 | 72.42 | 48.12 | 25.9 | Upgrade |
Depreciation & Amortization | 29.76 | 28.6 | 27.21 | 22.18 | 16.5 | Upgrade |
Other Amortization | 0.54 | 0.2 | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | 0 | -0.03 | 0.01 | 0.39 | - | Upgrade |
Provision & Write-off of Bad Debts | -5.82 | 6.26 | -1.39 | 0.62 | - | Upgrade |
Other Operating Activities | -4.02 | -0.96 | 4.91 | 0.74 | 10.8 | Upgrade |
Change in Accounts Receivable | -69.66 | -136.13 | -55.62 | -38.81 | -274.3 | Upgrade |
Change in Inventory | -103.89 | 33.62 | -15.91 | -35.57 | -145.5 | Upgrade |
Change in Accounts Payable | 32.01 | 5.26 | 38.89 | 17.49 | 253.5 | Upgrade |
Change in Other Net Operating Assets | 69.06 | 4.66 | 11.16 | 43.46 | - | Upgrade |
Operating Cash Flow | 48.92 | 24.38 | 81.67 | 58.62 | -113.1 | Upgrade |
Operating Cash Flow Growth | 100.67% | -70.15% | 39.32% | - | - | Upgrade |
Capital Expenditures | -31.87 | -24.78 | -65.92 | -59.13 | -169.6 | Upgrade |
Sale of Property, Plant & Equipment | 0.04 | 0.08 | 0.05 | 30.1 | - | Upgrade |
Investment in Securities | -0.85 | -3 | -0.87 | -0.14 | - | Upgrade |
Other Investing Activities | 1.05 | 0.94 | 0.71 | 0.6 | - | Upgrade |
Investing Cash Flow | -34.6 | -26.77 | -66.04 | -17.56 | -169.6 | Upgrade |
Short-Term Debt Issued | - | - | - | - | 101 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 49.5 | Upgrade |
Total Debt Issued | - | - | - | - | 150.5 | Upgrade |
Long-Term Debt Repaid | -5.2 | -4.9 | -4.6 | -1.5 | - | Upgrade |
Net Debt Issued (Repaid) | -5.2 | -4.9 | -4.6 | -1.5 | 150.5 | Upgrade |
Issuance of Common Stock | - | - | - | - | 41.5 | Upgrade |
Other Financing Activities | - | - | -13.57 | -56.21 | -9.2 | Upgrade |
Financing Cash Flow | -5.2 | -4.9 | -18.17 | -57.71 | 182.8 | Upgrade |
Net Cash Flow | 9.12 | -7.29 | -2.54 | -16.65 | -99.9 | Upgrade |
Free Cash Flow | 17.05 | -0.4 | 15.75 | -0.51 | -282.7 | Upgrade |
Free Cash Flow Margin | 1.13% | -0.03% | 1.12% | -0.04% | -23.10% | Upgrade |
Free Cash Flow Per Share | 0.20 | -0.01 | 0.19 | -0.01 | -3.41 | Upgrade |
Cash Interest Paid | - | - | 0.53 | 2.33 | 9.2 | Upgrade |
Cash Income Tax Paid | 38.02 | 31.66 | 24.95 | 17.95 | 9.3 | Upgrade |
Levered Free Cash Flow | -81.71 | -12.13 | -18.61 | -11.65 | -163.84 | Upgrade |
Unlevered Free Cash Flow | -76.37 | -8.11 | -14.99 | -8.48 | -158.9 | Upgrade |
Change in Working Capital | -72.48 | -92.6 | -21.48 | -13.43 | -166.3 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.